Endocrinology, Vol 126, 192-198, Copyright © 1990 by Endocrine Society

ARTICLES

Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy

A Sahu, CA Sninsky, PS Kalra and SP Kalra
Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville 32610.

Experimental diabetes adversely affects hypothalamic control of gonadotropin secretion and sex behavior and induces hyperphagia accompanied by severe body weight loss. Neuropeptide-Y (NPY) stimulates pituitary gonadotropin release, inhibits sexual behavior, and stimulates robust feeding in rats by acting at different sites in the hypothalamus. Therefore, we tested the hypothesis that altered hypothalamic NPY neurosecretion may mediate the constellation of effects observed in streptozotocin-induced diabetic (STZ-D) rats. Adult male rats were made diabetic by a single injection of STZ (50 mg/kg). Five months later, in vitro NPY release from the hypothalamic fragment encompassing the medial basal hypothalamus and preoptic area and NPY concentrations in seven hypothalamic sites were assessed. Basal NPY release was not significantly changed after STZ treatment. However, in response to a 30-min pulse of KCl (45 mM), NPY release from the medial basal hypothalamus-preoptic area of STZ-D rats was significantly increased compared to that in age-matched controls. In the STZ-D rats, NPY concentrations in six of the seven microdissected nuclei, including those mediating control of pituitary gonadotropin, sexual, and feeding behaviors, were increased compared to control values. In an additional study similar increments in NPY concentrations in the hypothalamic sites were observed 6 months after STZ treatment. The effects of insulin on NPY levels in microdissected hypothalamic sites in STZ- treated and BB diabetic rats was next assessed. One group of rats was treated with STZ, and the other group of rats was additionally treated with insulin (6 U/kg.day) for 3 months after development of diabetes with STZ. Again, STZ treatment alone, even for 3 months, increased NPY levels in all seven nuclei, including the suprachiasmatic nuclei. Insulin therapy completely prevented the STZ-induced increments in NPY levels in all hypothalamic sites, and the blood glucose level was 233 +/- 22 mg/dl in insulin-treated STZ-D rats and 496 +/- 6 mg/dl in untreated STZ-D rats. Similarly, NPY concentrations in five of the seven nuclei were unchanged in spontaneously diabetic BB rats (blood glucose, 435 +/- 67 mg/dl) maintained on insulin (5-8 U/kg.day). These results demonstrate that STZ-D rats have a widespread increase in NPY levels in hypothalamic sites, and there is an increase in the evoked release of NPY from the hypothalamus.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				H. Zheng, K. R. Bidasee, W. G. Mayhan, and K. P. Patel Lack of central nitric oxide triggers erectile dysfunction in diabetes Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1158 - R1164. [Abstract] [Full Text] [PDF]

				C. Namkoong, M. S. Kim, P. G. Jang, S. M. Han, H. S. Park, E. H. Koh, W. J. Lee, J. Y. Kim, I. S. Park, J. Y. Park, et al. Enhanced Hypothalamic AMP-Activated Protein Kinase Activity Contributes to Hyperphagia in Diabetic Rats Diabetes, January 1, 2005; 54(1): 63 - 68. [Abstract] [Full Text] [PDF]

				R. W. Gelling, J. Overduin, C. D. Morrison, G. J. Morton, R. S. Frayo, D. E. Cummings, and M. W. Schwartz Effect of Uncontrolled Diabetes on Plasma Ghrelin Concentrations and Ghrelin-Induced Feeding Endocrinology, October 1, 2004; 145(10): 4575 - 4582. [Abstract] [Full Text] [PDF]

				S. E. la Fleur, H. Ji, S. L. Manalo, M. I. Friedman, and M. F. Dallman The Hepatic Vagus Mediates Fat-Induced Inhibition of Diabetic Hyperphagia Diabetes, September 1, 2003; 52(9): 2321 - 2330. [Abstract] [Full Text] [PDF]

				D. K. Sindelar, P. Mystkowski, D. J. Marsh, R. D. Palmiter, and M. W. Schwartz Attenuation of Diabetic Hyperphagia in Neuropeptide Y-Deficient Mice Diabetes, March 1, 2002; 51(3): 778 - 783. [Abstract] [Full Text] [PDF]

				A. Inui Transgenic Approach to the Study of Body Weight Regulation Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62. [Abstract] [Full Text] [PDF]

				R. Alemzadeh and S. Holshouser Effect of Diazoxide on Brain Capillary Insulin Receptor Binding and Food Intake in Hyperphagic Obese Zucker Rats Endocrinology, July 1, 1999; 140(7): 3197 - 3202. [Abstract] [Full Text]

				B. Xu, P. S. Kalra, W. G. Farmerie, and S. P. Kalra Daily Changes in Hypothalamic Gene Expression of Neuropeptide Y, Galanin, Proopiomelanocortin, and Adipocyte Leptin Gene Expression and Secretion: Effects of Food Restriction Endocrinology, June 1, 1999; 140(6): 2868 - 2875. [Abstract] [Full Text]

				S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight Endocr. Rev., February 1, 1999; 20(1): 68 - 100. [Abstract] [Full Text]

				M. W. Schwartz, J. C. Erickson, D. G. Baskin, and R. D. Palmiter Effect of Fasting and Leptin Deficiency on Hypothalamic Neuropeptide Y Gene Transcription in Vivo Revealed by Expression of a lacZ Reporter Gene Endocrinology, May 1, 1998; 139(5): 2629 - 2635. [Abstract] [Full Text] [PDF]